This webinar covered:

  • What is health technology assessment (HTA)?
  • What is the HTA Policy and Methods Review (HTA Review) and why is it being done?
  • How can consumers get involved in the HTA Review?
  • The information, evidence and input the HTA Policy and Methods Review Reference Committee are seeking from consumers
  • The enhanced consumer engagement process and an update on work already underway
  • HTA and rare disease therapies
  • Key messages aligned with the National Strategic Action Plan for Rare Diseases